New York, US – October 21, 2018 Based on advanced technology and years of research, Creative Biolabs recently upgraded one-stop CAR-T development services that cover the entire process from biomarker identification to clinical trials.
Compared to traditional methods, immunotherapy turns out to be a revolutionary treatment with higher specificity and less toxicity for a wide range of diseases. Chimeric antigen receptor (CAR)-engineered T cell therapy is a remarkably promising approach to eliminating various kinds of tumors, especially for B cell malignancies, with up to 95% response rates and durable complete remission.
“CAR-T cells that bypass MHC restriction allow for direct activation of effector cells for the treatment of various types of tumors. Our one-stop CAR-T development services can offer customers superior approaches for scFv generation such as the one-stop solution for developing CAR from Hybridoma or Phage Display. Besides the classical route of CARs, scientists in Creative Biolabs who are familiar with all four CAR-T generations are also capable of designing special CARs, such as TanCAR, CAR modified NK cells, CAR-T cell therapy with CRISPR platform, etc.” said the manager in Creative Biolabs.
“In addition to CAR Design & Construction services, our team can professionally perform multiple evaluations on the post-transfection CAR-T cells to verify the solid success of CAR-T construction and superior function. Based on our advanced technologies and platforms, a full range of validation In Vitro & In Vivo Assay services are designed and operated to meet client’s specific T cells engineered objective.”
As a world-renowned service provider for immunotherapy, Creative Biolabs has one of the world’s largest collection of CAR products of different generations targeting various biomarkers, continuing to innovate the next generation CAR technologies to achieve even greater results.
About Creative Biolabs
As a global company, Creative Biolabs has more than 200 talented and well-trained scientists located in different continents working closely with partners from the entire world to develop and produce medicines of tomorrow. Specifically, the established leading experts in TCR and CAR T&NK cell immune therapy development offer the one-stop custom services that cover the entire new drug development pipeline, and an exclusive line of ready-to-use TCR and CAR T&NK cell construction products, such as virus packaging, purification, expansion and titer determination kits. Furthermore, a unique unparalleled CAR construction and production platform has been built up for all four CAR generations.
Company Name: Creative Biolabs
Contact Person: Bella Smith
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States